medigraphic.com
SPANISH

Revista Mexicana de Medicina Transfusional

ISSN 2007-6509 (Print)
Órgano oficial de la Asociación Mexicana de Medicina Transfusional A.C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2022, Number S1

<< Back Next >>

Rev Mex Med Transfus 2022; 14 (S1)

La transfusión de hematíes de fenotipo idéntico: ¿a quién y cuándo?

Muñiz-Díaz E
Full text How to cite this article 10.35366/107033

DOI

DOI: 10.35366/107033
URL: https://dx.doi.org/10.35366/107033

Language: Spanish
References: 10
Page: s85-91
PDF size: 136.83 Kb.


Key words:

No keywords




REFERENCES

  1. Castro O, Sandler SG, Houston-Yu P, Rana S. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications. Transfusion. 2002; 42 (6): 684-90.

  2. Schonewille H, Haak HL, van Zijl AM. Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases. Transfusion. 1999; 39 (7): 763-771.

  3. Tatari-Calderone Z, Minniti CP, Kratovil T, Stojakovic M, Vollmer A, Barjaktarevic I et al.. rs660 polymorphism in Ro52 (SSA1; TRIM21) is a marker for age-dependent tolerance induction and efficiency of alloimmunization in sickle cell disease. Mol Immunol. 2009; 47 (1): 64-70.

  4. Zimring JC, Welniak L, Semple JW, Ness PM, Slichter SJ, Spitalnik SL et al. Current problems and future directions of transfusion-induced alloimmunization: summary of an NHLBI working group. Transfusion. 2011; 51 (2): 435-441.

  5. Chou ST, Jackson T, Vege S, Smith-Whitley K, Friedman DF, Westhoff CM. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood. 2013; 122 (6): 1062-1071.

  6. Sippert EA, Visentainer JE, Alves HV, Rodrigues C, Gilli SC, Addas-Carvalho M et al. Red blood cell alloimmunization in patients with sickle cell disease: correlation with HLA and cytokine gene polymorphisms. Transfusion. 2017; 57 (2): 379-389.

  7. Compernolle V, Chou ST, Tanael S, Savage W, Howard J, Josephson CD et al. Red blood cell specifications for patients with hemoglobinopathies: a systematic review and guideline. Transfusion. 2018; 58 (6): 1555-1566.

  8. Fasano RM, Meyer EK, Branscomb J, White MS, Gibson RW, Eckman JR. Impact of red blood cell antigen matching on alloimmunization and transfusion complications in patients with sickle cell disease: a systematic review. Transfus Med Rev. 2019; 33 (1): 12-23.

  9. Meinderts SM, Gerritsma JJ, Sins JWR, de Boer M, van Leeuwen K, Biemond BJ et al. Identification of genetic biomarkers for alloimmunization in sickle cell disease. Br J Haematol. 2019; 186 (6): 887-899.

  10. Trompeter S, Massey E, Robinson S; Transfusion Task Force of the British Society of Haematology Guidelines Committee. Position paper on International Collaboration for Transfusion Medicine (ICTM) Guideline 'Red blood cell specifications for patients with hemoglobinopathies: a systematic review and guideline'. Br J Haematol. 2020; 189 (3): 424-427.




Table 1
Table 2
Table 3

2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Med Transfus. 2022;14